Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system

Nigrostriatal dopamine transporter availability in early Parkinson's disease

(2018) Patrik Fazio et al.   MOVEMENT DISORDERS

Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI

(2018) Yue Xing et al.   MOVEMENT DISORDERS

11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study

(2017) Weihua Li et al.   MOVEMENT DISORDERS

Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D 2 receptors

(2017) Hiroshi Ito et al.   NEUROIMAGE

Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease

(2017) Laura Saari et al.   NEUROLOGY

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

(2017) Fabio A. Zucca et al.   PROGRESS IN NEUROBIOLOGY

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease

(2017) Silvia Paola Caminiti et al.   NeuroImage-Clinical

Synaptic failure and α-synuclein

(2016) Laura Calo et al.   MOVEMENT DISORDERS

Correlation between neuromelanin-sensitive MR imaging and 123I-FP-CIT SPECT in patients with parkinsonism

(2016) Keita Kuya et al.   NEURORADIOLOGY

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease

(2016) Ioannis U. Isaias et al.   Frontiers in Aging Neuroscience

Retrograde Axonal Degeneration in Parkinson Disease

(2016) Patricia Tagliaferro et al.   Journal of Parkinsons Disease

Is Axonal Degeneration a Key Early Event in Parkinson’s Disease?

(2016) Zuzanna Kurowska et al.   Journal of Parkinsons Disease

Subregional Pattern of Striatal Dopamine Transporter Loss on 18F FP-CIT Positron Emission Tomography in Patients With Pure Akinesia With Gait Freezing

(2016) Sangwon Han et al.   JAMA Neurology

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

(2015) Gabriel Castellanos et al.   MOVEMENT DISORDERS

Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I

(2014) Yoshitoshi Shingai et al.   ANNALS OF NUCLEAR MEDICINE

Substantia nigra neuromelanin magnetic resonance imaging inde novoParkinson's disease patients

(2014) S. Reimão et al.   EUROPEAN JOURNAL OF NEUROLOGY

Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts

(2014) Julia Kraemmer et al.   MOVEMENT DISORDERS

The place of dopamine in the cortico-basal ganglia circuit

(2014) S.N. Haber   NEUROSCIENCE

Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

(2013) Jeffrey H. Kordower et al.   BRAIN

Neuromelanin Magnetic Resonance Imaging in Parkinson's Disease and Multiple System Atrophy

(2013) Keita Matsuura et al.   EUROPEAN NEUROLOGY

Parcellation of the human substantia nigra based on anatomical connectivity to the striatum

(2013) Rumana Chowdhury et al.   NEUROIMAGE

Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies

(2013) Shinichiro Kitao et al.   NEURORADIOLOGY

3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease

(2013) Kimihiro Ogisu et al.   NEURORADIOLOGY

Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging

(2013) Chigumi Ohtsuka et al.   NEUROSCIENCE LETTERS

Neuromelanin of the Human Substantia Nigra: An Update

(2013) Fabio A. Zucca et al.   NEUROTOXICITY RESEARCH

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias

(2012) S. J. Colloby et al.   BRAIN

Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy

(2012) M. Oh et al.   JOURNAL OF NUCLEAR MEDICINE

Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease

(2011) Kenichi Kashihara et al.   JOURNAL OF CLINICAL NEUROSCIENCE

T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease

(2011) Stefan T. Schwarz et al.   MOVEMENT DISORDERS

FSL

(2011) Mark Jenkinson et al.   NEUROIMAGE

Clinical progression in Parkinson disease and the neurobiology of axons

(2010) Hsiao-Chun Cheng et al.   ANNALS OF NEUROLOGY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

(2010) Andri C. Tziortzi et al.   NEUROIMAGE

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study

(2009) R. Nandhagopal et al.   BRAIN

Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum

(2009) Kenji Ishibashi et al.   SYNAPSE

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS